WallStreetZenWallStreetZen

NASDAQ: AADI
Aadi Bioscience Inc Stock

$4.30-0.54 (-11.16%)
Updated Oct 2, 2023
AADI Price
$4.30
Fair Value Price
$5.57
Market Cap
$105.44M
52 Week Low
$4.16
52 Week High
$14.57
P/E
-1.79x
P/B
0.8x
P/S
8.54x
PEG
N/A
Dividend Yield
N/A
Revenue
$21.54M
Earnings
-$61.58M
Gross Margin
90.7%
Operating Margin
-284.85%
Profit Margin
-285.9%
Debt to Equity
0.15
Operating Cash Flow
-$58M
Beta
0.55
Next Earnings
Nov 7, 2023
Ex-Dividend
N/A
Next Dividend
N/A

AADI Overview

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AADI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AADI ($4.30) is undervalued by 22.76% relative to our estimate of its Fair Value price of $5.57 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AADI ($4.30) is significantly undervalued by 22.76% relative to our estimate of its Fair Value price of $5.57 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
AADI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AADI due diligence checks available for Premium users.

Be the first to know about important AADI news, forecast changes, insider trades & much more!

AADI News

Valuation

AADI fair value

Fair Value of AADI stock based on Discounted Cash Flow (DCF)
Price
$4.30
Fair Value
$5.57
Undervalued by
22.76%
AADI ($4.30) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AADI ($4.30) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AADI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

AADI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.79x
Industry
14.19x
Market
12.38x

AADI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.8x
Industry
5.05x
AADI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AADI's financial health

Profit margin

Revenue
$6.2M
Net Income
-$18.0M
Profit Margin
-289.8%
AADI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AADI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$151.2M
Liabilities
$19.8M
Debt to equity
0.15
AADI's short-term assets ($144.92M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AADI's short-term assets ($144.92M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AADI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AADI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$16.8M
Investing
$50.6M
Financing
$313.0k
AADI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AADI vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
AADI$105.44M-11.16%-1.79x0.80x
PRQR$105.31M-3.85%-1.57x1.81x
CTXR$105.96M-2.49%-3.34x1.08x
SGMO$106.27M0.00%-0.50x0.45x
INO$104.28M0.00%-0.60x0.62x

Aadi Bioscience Stock FAQ

What is Aadi Bioscience's quote symbol?

(NASDAQ: AADI) Aadi Bioscience trades on the NASDAQ under the ticker symbol AADI. Aadi Bioscience stock quotes can also be displayed as NASDAQ: AADI.

If you're new to stock investing, here's how to buy Aadi Bioscience stock.

What is the 52 week high and low for Aadi Bioscience (NASDAQ: AADI)?

(NASDAQ: AADI) Aadi Bioscience's 52-week high was $14.57, and its 52-week low was $4.16. It is currently -70.48% from its 52-week high and 3.37% from its 52-week low.

How much is Aadi Bioscience stock worth today?

(NASDAQ: AADI) Aadi Bioscience currently has 24,519,860 outstanding shares. With Aadi Bioscience stock trading at $4.30 per share, the total value of Aadi Bioscience stock (market capitalization) is $105.44M.

Aadi Bioscience stock was originally listed at a price of $90.00 in Aug 9, 2017. If you had invested in Aadi Bioscience stock at $90.00, your return over the last 6 years would have been -95.22%, for an annualized return of -39.76% (not including any dividends or dividend reinvestments).

How much is Aadi Bioscience's stock price per share?

(NASDAQ: AADI) Aadi Bioscience stock price per share is $4.30 today (as of Oct 2, 2023).

What is Aadi Bioscience's Market Cap?

(NASDAQ: AADI) Aadi Bioscience's market cap is $105.44M, as of Oct 3, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Aadi Bioscience's market cap is calculated by multiplying AADI's current stock price of $4.30 by AADI's total outstanding shares of 24,519,860.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.